China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People's Republic of China. It operates through Agency Services and Healthcare Related Services segments. The company acts as agent for clients to sell proprietary pharmaceutical products and artificial intelligence bone density testings to external customers. It also provides healthcare related research and promotion services in relation to bone health knowledge. In addition, the company is involved in trading of prescription medicines; and provision of agency and healthcare related services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Central, Hong Kong.
Frequently asked questions
What sector does China NT Pharma Group Co Ltd (1011) operate in?
China NT Pharma Group Co Ltd belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is China NT Pharma Group Co Ltd (1011) current stock price?
As of the latest data, China NT Pharma Group Co Ltd stock price is HK$0.36, with a previous close of HK$0.36.
What is China NT Pharma Group Co Ltd (1011) current market capitalization?
China NT Pharma Group Co Ltd market cap is approximately 646.76 million.
What is China NT Pharma Group Co Ltd (1011) EBITDA?
China NT Pharma Group Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -971.40 thousand.
Does China NT Pharma Group Co Ltd (1011) pay dividends?
No. China NT Pharma Group Co Ltd does not pay a dividend.
What is China NT Pharma Group Co Ltd (1011) beta (volatility) score?
China NT Pharma Group Co Ltd has a beta of -1.989, indicating lower volatility than the overall market.
